Hookipa Pharma
IPO- Website
- hookipapharma.com
- Total Funding
- $159.8M
- Last Round
- $21.3M Corporate RoundDec 2023
- Rounds
- 5
About
Arenavirus vector-based immunotherapy for cancer and HIV
Summary
It has raised $159.8M in total across 5 rounds, most recently a $21.3M Corporate Round round in Dec 2023. Investors include Redmile Group, Forbion Capital Partners and Sofinnova Partners.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
$21.3M
Dec 2023
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
